The Food and Drug Administration (FDA) is advising consumers not to purchase or use Jianbu Huqian Wan, a product promoted for joint pain. This product was identified by FDA during an examination of international mail shipments. FDA laboratory analysis confirmed that Jianbu Huqian Wan contains dexamethasone, a corticosteroid, chlorpheniramine, and furosemide.
Consumers taking Jianbu Huqian Wan are urged to immediately consult with their health care provider to safely discontinue use of this product. The risks of withdrawal from corticosteroids should be assessed by a health care professional. Only licensed health care professionals can evaluate patients for the risk, or confirm the existence, of adrenal suppression. To date, FDA is not aware of any reports of adverse events related to this product.
Dexamethasone is a corticosteroid commonly used to treat inflammatory conditions. Consumers are advised that corticosteroid use can impair a person’s ability to fight infections, cause high blood sugar levels, muscle injuries and psychiatric problems. When corticosteroids are taken for a prolonged period, or at high doses, they can suppress the adrenal gland and cause withdrawal symptoms with abrupt discontinuation.
Chlorpheniramine is an antihistamine generally used for allergies. Antihistamines may cause drowsiness and affect mental alertness.
Furosemide is the active pharmaceutical ingredient in Lasix, a potent diuretic which is available only through prescription for use in the treatment of congestive heart failure, high blood pressure, and edema. It can cause profound dehydration and electrolyte imbalance, with loss of potassium, calcium, sodium, and magnesium. Patients allergic to sulfonamides may also be allergic to furosemide. Serious adverse effects from overdose may lead to dehydration, seizures, gastrointestinal problems, kidney damage, lethargy (tiredness), collapse, and coma.
In addition, these undeclared ingredients in Jianbu Huqian Wan may cause serious side effects when combined with other medications.
Please refer to the following website in FDA for details:
http://www.fda.gov/Drugs/ResourcesForYou/../ucm445577.htm
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/ Tuesday, May 05, 2015
Issued at HKT 15:00
|
